April 2010 Archives

April 27, 2010

Who's Accountable For Faulty New Mexico Medical Devices?

A recent New York Times article posed the following question:

Who should be accountable when a company sells a flawed product that can injure or kill patients? Is it the company or the people who run it?

We believe it's both.

We have seen hundreds of individuals throughout New Mexico who have had surgery, only to sustain injuries as the result of a physician implanting a defective product such as the Zimmer Durom Cup. Many parties may be responsible in such cases - including the company, the executives running the company, and even the physicians.

However, those people who are not responsible and must be compensated are the innocent patients who seek medical attention to improve their condition, only to sustain further injury.

In 2006, the Zimmer Durom Cup was introduced and intended to be an improvement over previous hip replacement products. However, rather than being an improvement, it caused significant pain and discomfort, as well as a loosening of the hip implants, requiring additional surgeries.

The use of defective Zimmer Durom Cups in hip replacement surgeries has led to dozens of lawsuits cropping up all around the country. Currently, at least 51 product liability lawsuits in 10 different states are currently pending against the Zimmer Durum Cup, a defective part that implanted during hip replacement surgery.

Continue reading "Who's Accountable For Faulty New Mexico Medical Devices? " »

April 7, 2010

NEW MEXICO DANGEROUS DRUGS - AVANDIA RESEARCHERS TIED TO CONFLICTS OF INTERESTS

According to Bloomberg News, 94% of researchers who found positive results from using Avandia had financial ties to pharmaceutical companies. Avandia, is a controversial diabetes drug that has been linked to increased sharp increased risk of heart attack and death.

Despite the FDA's issuance of a formal safety alert concerning the risks associated with Avandia, GlaxoSmithKline continues to market and sell the drug.

The FDA has now also decided to hold public hearings in July to determine whether Avandia should be removed from the market after scores of lawsuits in New Mexico and across the country have been filed based on the increased risk of heart attack resulting from Avandia usage, along with several studies showing a substantial correlation.

While reviewing documents in preparation for the hearing, Mayo Clinic researchers noted that an astounding 45% of the researchers who had weighed in on the Avandia controversy had financial conflicts of interests and about a quarter of those failed to report those conflicts.

Continue reading "NEW MEXICO DANGEROUS DRUGS - AVANDIA RESEARCHERS TIED TO CONFLICTS OF INTERESTS" »